147 related articles for article (PubMed ID: 28544751)
41.
Chen C; Li J; Jiang T; Tang J; Zhang Z; Luo Y; Wang X; Sun K; Jiang Z; Zhou J; Liu Z
Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428825
[TBL] [Abstract][Full Text] [Related]
42. Frequent IDH1/2 mutations in intracranial chondrosarcoma: a possible diagnostic clue for its differentiation from chordoma.
Arai M; Nobusawa S; Ikota H; Takemura S; Nakazato Y
Brain Tumor Pathol; 2012 Oct; 29(4):201-6. PubMed ID: 22323113
[TBL] [Abstract][Full Text] [Related]
43. A case of myelopathy because of enchondromas from Maffucci syndrome with successful surgical treatment.
McCarthy CM; Blecher H; Reich S
Spine J; 2015 Jun; 15(6):e15-9. PubMed ID: 25777744
[TBL] [Abstract][Full Text] [Related]
44. Mutant IDH is sufficient to initiate enchondromatosis in mice.
Hirata M; Sasaki M; Cairns RA; Inoue S; Puviindran V; Li WY; Snow BE; Jones LD; Wei Q; Sato S; Tang YJ; Nadesan P; Rockel J; Whetstone H; Poon R; Weng A; Gross S; Straley K; Gliser C; Xu Y; Wunder J; Mak TW; Alman BA
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2829-34. PubMed ID: 25730874
[TBL] [Abstract][Full Text] [Related]
45. Genomic Profiling Identifies Association of
Zhu GG; Nafa K; Agaram N; Zehir A; Benayed R; Sadowska J; Borsu L; Kelly C; Tap WD; Fabbri N; Athanasian E; Boland PJ; Healey JH; Berger MF; Ladanyi M; Hameed M
Clin Cancer Res; 2020 Jan; 26(2):419-427. PubMed ID: 31615936
[TBL] [Abstract][Full Text] [Related]
46. The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation.
Molenaar RJ; Radivoyevitch T; Maciejewski JP; van Noorden CJ; Bleeker FE
Biochim Biophys Acta; 2014 Dec; 1846(2):326-41. PubMed ID: 24880135
[TBL] [Abstract][Full Text] [Related]
47. Do intracranial neoplasms differ in Ollier disease and maffucci syndrome? An in-depth analysis of the literature.
Ranger A; Szymczak A
Neurosurgery; 2009 Dec; 65(6):1106-13; discussion 1113-5. PubMed ID: 19934970
[TBL] [Abstract][Full Text] [Related]
48. Acute myeloid leukemia with IDH1 or IDH2 mutation: frequency and clinicopathologic features.
Patel KP; Ravandi F; Ma D; Paladugu A; Barkoh BA; Medeiros LJ; Luthra R
Am J Clin Pathol; 2011 Jan; 135(1):35-45. PubMed ID: 21173122
[TBL] [Abstract][Full Text] [Related]
49. Endoscopic Endonasal Approach in Skull Base Chondrosarcoma Associated with Maffucci Syndrome: Case Series and Literature Review.
Beer-Furlan A; Balsalobre L; Vellutini EA; Stamm AC
World Neurosurg; 2016 Jan; 85():365.e7-15. PubMed ID: 26348567
[TBL] [Abstract][Full Text] [Related]
50.
Srinivasan A; Zhou Y; Scordino T; Prabhu S; Wierenga A; Simon G; Wierenga KJ; Thompson J; Shah R; Sinha AA
Pediatr Hematol Oncol; 2020 Aug; 37(5):431-437. PubMed ID: 32166993
[TBL] [Abstract][Full Text] [Related]
51. [Anesthetic management of a patient with Maffucci syndrome for removal of a pituitary adenoma].
Imai E; Kawamata T; Yamamoto K; Mochidome M; Kawamata M
Masui; 2012 May; 61(5):538-41. PubMed ID: 22702097
[TBL] [Abstract][Full Text] [Related]
52. The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo.
Suijker J; Baelde HJ; Roelofs H; Cleton-Jansen AM; Bovée JV
Oncotarget; 2015 Jun; 6(17):14832-42. PubMed ID: 26046462
[TBL] [Abstract][Full Text] [Related]
53. Isocitrate dehydrogenase mutation hot spots in acute lymphoblastic leukemia and oral cancer.
Tang JY; Chang CC; Lin PC; Chang JG
Kaohsiung J Med Sci; 2012 Mar; 28(3):138-44. PubMed ID: 22385606
[TBL] [Abstract][Full Text] [Related]
54. Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL.
Simonin M; Schmidt A; Bontoux C; Dourthe MÉ; Lengliné E; Andrieu GP; Lhermitte L; Graux C; Grardel N; Cayuela JM; Huguet F; Arnoux I; Ducassou S; Macintyre E; Gandemer V; Dombret H; Petit A; Ifrah N; Baruchel A; Boissel N; Asnafi V
J Hematol Oncol; 2021 May; 14(1):74. PubMed ID: 33941203
[TBL] [Abstract][Full Text] [Related]
55. [Analysis of IDH1 and IDH2 mutations in patients with acute myeloid leukemia].
Jia ZX; Zhou M; Chao HY; Lu XZ; Zhang R; Cen L; Xiao R; Jiang NK
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):397-401. PubMed ID: 22781800
[TBL] [Abstract][Full Text] [Related]
56. Disruption of the HIF-1 pathway in individuals with Ollier disease and Maffucci syndrome.
Poll SR; Martin R; Wohler E; Partan ES; Walek E; Salman S; Groepper D; Kratz L; Cernach M; Jesus-Garcia R; Haldeman-Englert C; Choi YJ; Morris CD; Cohen B; Hoover-Fong J; Valle D; Semenza GL; Sobreira NLM
PLoS Genet; 2022 Dec; 18(12):e1010504. PubMed ID: 36480544
[TBL] [Abstract][Full Text] [Related]
57. The malignant potential of enchondromatosis.
Schwartz HS; Zimmerman NB; Simon MA; Wroble RR; Millar EA; Bonfiglio M
J Bone Joint Surg Am; 1987 Feb; 69(2):269-74. PubMed ID: 3805090
[TBL] [Abstract][Full Text] [Related]
58. Rapid screening of ASXL1, IDH1, IDH2, and c-CBL mutations in de novo acute myeloid leukemia by high-resolution melting.
Ibáñez M; Such E; Cervera J; Luna I; Gómez-Seguí I; López-Pavía M; Dolz S; Barragán E; Fuster O; Llop M; Rodríguez-Veiga R; Avaria A; Oltra S; Senent ML; Moscardó F; Montesinos P; Martínez-Cuadrón D; Martín G; Sanz MA
J Mol Diagn; 2012 Nov; 14(6):594-601. PubMed ID: 22929312
[TBL] [Abstract][Full Text] [Related]
59. Synovial sarcoma complicating Maffucci syndrome.
Gammoudi R; Aounallah A; Belajouza C; Nouira R
Indian J Dermatol Venereol Leprol; 2019; 85(3):291-294. PubMed ID: 29667613
[TBL] [Abstract][Full Text] [Related]
60. Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients.
Verdegaal SH; Bovée JV; Pansuriya TC; Grimer RJ; Ozger H; Jutte PC; San Julian M; Biau DJ; van der Geest IC; Leithner A; Streitbürger A; Klenke FM; Gouin FG; Campanacci DA; Marec-Berard P; Hogendoorn PC; Brand R; Taminiau AH
Oncologist; 2011; 16(12):1771-9. PubMed ID: 22147000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
